With upside potential, Stoke Therapeutics Inc (STOK) Stock is well-positioned to grow

TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]

There is no better tap than Stoke Therapeutics Inc (STOK) Stock

TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]

Yummy or too sour? Stoke Therapeutics Inc (STOK) Stock

TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]

Are Stoke Therapeutics Inc’s (STOK) stock prices rising too high?

TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]

Stoke Therapeutics Inc (STOK) Stock is poised for a successful quarter

TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]

Growing at an Unbelievable Rate: Stoke Therapeutics Inc (STOK) Stock

TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]

Stoke Therapeutics Inc (STOK) Stock: Thought Concerns

TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]